Chase AIPricingFAQs
Display currency
Loading news…

9th Dimension Biotech

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Thousand Oaks, California, United States Founded 2013 1-10 employees For Profit

9D Biotech is the first company in the world to launch an age-reversing product line containing OSMOTIN®.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
2

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
24
IT spend
$96K

Company Info

Founded
2013
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
HQ
Thousand Oaks, California, United States
Region
Greater Los Angeles Area, West Coast, Western US
Diversity spotlight
Women Founded

Signals & Scores

Heat score
High
Growth score
Low
Trend (7d)
0
Trend (30d)
-0.6
Trend (90d)
-0.5

Key People at 9th Dimension Biotech

Founder and CEO
Founder and President
2
professional contacts at 9th Dimension Biotech
Contact execs at 9th Dimension Biotech

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to 9th Dimension Biotech

Loading news…

FAQs about 9th Dimension Biotech

People who checked this page also checked these

Browse the full Acquirezy directory.
9th Dimension Biotech - Company Profile, Full Acquisitions List, Funding and Investments